ID   PI15_CHICK              Reviewed;         258 AA.
AC   Q98ST6;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   07-APR-2021, entry version 103.
DE   RecName: Full=Peptidase inhibitor 15;
DE   AltName: Full=SugarCrisp;
DE   Flags: Precursor;
GN   Name=PI15;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RC   TISSUE=Limb bud;
RX   PubMed=11287197; DOI=10.1016/s0925-4773(01)00293-3;
RA   Smith D.M., Collins-Racie L.A., Marigo V.A., Roberts D.J., Davis N.M.,
RA   Hartmann C., Schweitzer R., LaVallie E.R., Gamer L., McCoy J., Tabin C.J.;
RT   "Cloning and expression of a novel cysteine-rich secreted protein family
RT   member expressed in thyroid and pancreatic mesoderm within the chicken
RT   embryo.";
RL   Mech. Dev. 102:223-226(2001).
RN   [2]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND INDUCTION BY NOG AND RETINOIC ACID.
RX   PubMed=26385749; DOI=10.1016/j.ydbio.2015.09.007;
RA   Nimmagadda S., Buchtova M., Fu K., Geetha-Loganathan P.,
RA   Hosseini-Farahabadi S., Trachtenberg A.J., Kuo W.P., Vesela I.,
RA   Richman J.M.;
RT   "Identification and functional analysis of novel facial patterning genes in
RT   the duplicated beak chicken embryo.";
RL   Dev. Biol. 407:275-288(2015).
CC   -!- FUNCTION: Serine protease inhibitor which displays weak inhibitory
CC       activity against trypsin (By similarity). May play a role in facial
CC       patterning during embryonic development (PubMed:26385749).
CC       {ECO:0000250|UniProtKB:O43692, ECO:0000269|PubMed:26385749}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:O43692}.
CC   -!- DEVELOPMENTAL STAGE: First expressed the mesoderm of the emerging
CC       dorsal pancreatic bud at stage 17-18. Also expressed in the thyroid
CC       anlagen. Expression persists throughout the dorsal pancreatic mesoderm
CC       through E6 as the pancreas continues to enlarge. After E6, the amount
CC       of mesoderm in the pancreas declines to a minimal level and little or
CC       no expression is seen. The expression in the mesoderm of the thyroid
CC       persists at least through E8 in the development of this organ. Weakly
CC       expressed within the emerging lung buds and developing gut. Also
CC       expressed in developing carniofacial structures. At stage 17,
CC       expression is restricted to the cranial paraxial mesoderm. At stage 24,
CC       expressed in the corners of the frontonasal mass (globular processes)
CC       where the lip will fuse. At stage 26 through 29, becomes focused in the
CC       center of the frontonasal mass. At stage 30, further restricted to the
CC       future egg tooth. By stage 34, found in the egg tooth and structures
CC       derived from the frontonasal mass, such as the premaxillary mesenchyme
CC       (PubMed:26385749). {ECO:0000269|PubMed:11287197,
CC       ECO:0000269|PubMed:26385749}.
CC   -!- INDUCTION: Up-regulated by Noggin/NOG and retinoic acid. May be a
CC       direct retinoic acid target. {ECO:0000269|PubMed:26385749}.
CC   -!- MISCELLANEOUS: Was named SugarCrisp after the breakfast cereal.
CC   -!- SIMILARITY: Belongs to the CRISP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF329195; AAK16493.1; -; mRNA.
DR   RefSeq; NP_989665.1; NM_204334.1.
DR   STRING; 9031.ENSGALP00000035875; -.
DR   PaxDb; Q98ST6; -.
DR   Ensembl; ENSGALT00000065508; ENSGALP00000051751; ENSGALG00000029264.
DR   GeneID; 374241; -.
DR   KEGG; gga:374241; -.
DR   CTD; 51050; -.
DR   eggNOG; KOG3017; Eukaryota.
DR   GeneTree; ENSGT00940000158635; -.
DR   HOGENOM; CLU_035730_2_2_1; -.
DR   InParanoid; Q98ST6; -.
DR   OMA; RHVACQS; -.
DR   OrthoDB; 1528782at2759; -.
DR   PhylomeDB; Q98ST6; -.
DR   TreeFam; TF316148; -.
DR   PRO; PR:Q98ST6; -.
DR   Proteomes; UP000000539; Chromosome 2.
DR   Bgee; ENSGALG00000015659; Expressed in colon and 2 other tissues.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0030414; F:peptidase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.33.10; -; 1.
DR   InterPro; IPR018244; Allrgn_V5/Tpx1_CS.
DR   InterPro; IPR014044; CAP_domain.
DR   InterPro; IPR035940; CAP_sf.
DR   InterPro; IPR001283; CRISP-related.
DR   PANTHER; PTHR10334; PTHR10334; 1.
DR   Pfam; PF00188; CAP; 1.
DR   PRINTS; PR00837; V5TPXLIKE.
DR   SMART; SM00198; SCP; 1.
DR   SUPFAM; SSF55797; SSF55797; 1.
DR   PROSITE; PS01010; CRISP_2; 1.
PE   2: Evidence at transcript level;
KW   Developmental protein; Glycoprotein; Protease inhibitor;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   PROPEP          22..60
FT                   /evidence="ECO:0000250|UniProtKB:O43692"
FT                   /id="PRO_0000287626"
FT   CHAIN           61..258
FT                   /note="Peptidase inhibitor 15"
FT                   /id="PRO_0000287627"
FT   DOMAIN          71..211
FT                   /note="SCP"
FT   CARBOHYD        26
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        36
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        124
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   258 AA;  29239 MW;  3FD853945B92FF35 CRC64;
     MTIIAAISCV FLFSILCETS ALVLPNSTDL LLSNNNFTDI ETALAAHLDS AKIPKARRKR
     YISQNDMIAI LDYHNQVRGK VFPPASNMEY MVWDETLAKS AEAWAATCIW DHGPSYLLRF
     LGQNLSVRTG RYRSILQLVK PWYDEVKDYA FPYPQDCNPR CPMRCYGPMC THYTQMVWAT
     SNRIGCAIHT CQNMNVWGSV WRRAVYLVCN YAPKGNWIGE APYKVGVPCS ACPPSYGGSC
     TDNLCFPGVT SNYLYWFK
//
